Validation and Comparison of Two Analytical Methods for Imatinib Therapeutic Drug Monitoring

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Andreas Hochhaus, Richard A. Larson, François Guilhot et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Selectivity in analytical chemistry (IUPAC Recommendations 2001)

Jörgen Vessman, Jacobus F. van Staden, Klaus Danzer et al. · Pure and Applied Chemistry · 2001 · 261 citations · Full text

Natural Sciences, Chemistry, Analytical Chemistry +3

Chronic myeloid leukemia: 2016 update on diagnosis, therapy, and monitoring

Elias Jabbour, Hagop M. Kantarjian · American Journal of Hematology · 2016 · 183 citations

Medicine, Hematology, Oncology +17

Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS

Irina Andriamanana, Inès Gana, Bénédicte Duretz et al. · Journal of Chromatography B · 2013 · 117 citations

Medicine, Oncology, Pharmacology +10

High throughput routine determination of 17 tyrosine kinase inhibitors by LC–MS/MS

C Merienne, Marine Rousset, Dominique Ducint et al. · Journal of Pharmaceutical and Biomedical Analysis · 2017 · 117 citations

Pharmacy, Medicinal Chemistry, Pharmacology +10